N4 Pharma PLC Holding(s) in Company (9988Y)
08 Gennaio 2024 - 5:24PM
UK Regulatory
TIDMN4P
RNS Number : 9988Y
N4 Pharma PLC
08 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BYW8QM32
Issuer Name
N4 PHARMA PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
IG Markets Limited
City of registered office (if applicable)
London
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s)
subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
05-Jan-2024
6. Date on which Issuer notified
08-Jan-2024
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 0.000000 3.208694 3.208694 8624339
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable)
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
Sub Total 8.A
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Equity swaps Cash 8624339 3.208694
================ ================== ==================
Sub Total 8.B2 8624339 3.208694%
================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is higher through financial equals or is higher
than the notifiable instruments if it than the notifiable
threshold equals or is higher threshold
than the notifiable
threshold
IG Group Holdings IG Markets Limited 3.208694 3.208694%
=============================================== ===================== =====================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
IG Markets Limited ('IGM') is a subsidiary of IG Group, the
ultimate controlling person of which is IG Group Holdings plc.
('IGGH')
IGM is 100% owned by IGGH through its subsidiaries, IG Group Ltd
('IGGL'), and Market Data Limited ('MDL').
12. Date of Completion
08-Jan-2024
13. Place Of Completion
London
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLFLFFRLVITIIS
(END) Dow Jones Newswires
January 08, 2024 11:24 ET (16:24 GMT)
Grafico Azioni N4 Pharma (LSE:N4P)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni N4 Pharma (LSE:N4P)
Storico
Da Nov 2023 a Nov 2024
